Aspiration and sclerotherapy with ethanol is a minimal-invasive, safe, and inexpensive outpatient treatment method with acceptable short- and long-term results in ADPKD patients. Aspiration and sclerotherapy with ethanol can be an option for patients with ADPKD.
Objective: The most crucial steps of percutaneous nephrolithotomy (PCNL) are the percutaneous access and dilation of the access route. Recent literature suggests that papillary access to renal calyx is the accepted method. Despite this rule, we do not always make papillary puncture and we puncture wherever we can to achieve stone-free status and reduce unnecessary access. In this study, we present our results with papillary vs non-papillary access in patients with a kidney stone. Material and methods: Two hundred and seven patients with non-papillary access and 69 patients with papillary access who had similar demographics (age, body mass index (BMI), stone size) were selected with pair match analysis (3:1). Preoperative and postoperative data were collected from the patient's chart. Operative time (from starting surgery to nephrostomy tube), drop-in hematocrit level, transfusion rate, duration of hospital stay, perioperative and postoperative complications (Clavien-Dindo Classification) and stone-free status (no or < 3 mm residual stone) were also evaluated in both groups. Results: The mean operative time was similar in between two groups. The mean hematocrit decreases not differ between the two groups (p = 0.56). In papillary group, only 2 patients (3.2%) required transfusion and only one patient (1.4%) in the non-papillary group had a transfusion with no statistically significant difference (p = 0.43). The overall complication rates were 7.1% in the papillary group and 7.2% in the non-papillary group (p = 0.89). Postoperative mean creatinine level was similar between the two groups. Conclusions: In this study, we found that non-papillary access is a feasible option for PCNL in the terms of stone-free status and complication rates.
Objective:To compare the open simple prostatectomy (OSP) and laparoscopic simple prostatectomy (LSP) performed due to benign prostatic enlargement greater than 80 cc. Materials and Methods: Between January 2015 and July 2021, patients who underwent OSP and LSP were retrospectively screened. The patients' demographic, preoperative, perioperative, and postoperative data were noted and compared. Results: The data of a total of 90 patients, including 55 (61.1%) cases in the OSP and 35 cases (38.9%) in the LSP group were analyzed. Age, comorbidity rates, and body mass index scores of the patients were comparable. There was also no significant difference in the preoperatively calculated mean prostate volume, and Qmax of the cases. The mean operative time was significantly longer for LSP (p<0.0001). The median blood loss was 368 cc (250) and 80 cc (35) in the OSP and LSP groups, respectively, indicating significantly higher values in the OSP group (p<0.0001). The mean hospital stay was statistically significantly higher in the OSP group (8.1±4.3 days) compared to the LSP group (3.6±1 days) (p<0.0001). Minor complications were observed in 21 (38.2%) patients in the OSP and five (14.2%) patients in the LSP group with a significant intergroup difference (p=0.007).
Conclusion:Laparoscopic technique is a safe and effective procedure for large prostatic adenomas. Compared to open surgery, LSP has a longer operative time but is associated with greater patient comfort and lower complication rates.
Kronik oral antikoagülan kullanımının robotik radikal prostatektomi sonuçlarına etkisiThe impact of chronic oral anticoagulant therapy on robotic radical prostatectomy outcomes Özet Amaç: Kardiyovasküler hastalıklar nedeniyle kronik oral antikoagulan (KOA) kullanımının robotik radikal prostatektomi sonuçlarına etkisini araştırmak.Materials and Methods: Kliniğimizde 2008-2012 yılları arasında prostat kanseri tanısıyla robotik radikal prostatektomi uygulanan 200 hasta çalışmaya alındı. Birinci grupta kronik oral antikoagulan kullanan hastalara operasyondan bir hafta önce oral antikoagulan tedavi kesilerek düşük molekül ağırlıklı heparin (DMAH) başlandı ve ameliyat sonrası bir hafta devam edildi. İkinci grup, KOA kullanım öyküsü bulunmayan hastalar olup, ameliyat öncesi bir gün ve mobilizasyona kadar geçen süre boyunca düşük molekül ağırlıklı heparin subkutan profilaktik olarak verildi. Her iki grup operasyon süresi, ortalama kan kaybı, transfüzyon ihtiyacı, dren çekilme süresi, komplikasyon oranları ve hastanede kalış süreleri açısından karşılaştırıldı.Bulgular: Çalışmaya dahil edilen hastaların 24'ü oral antikoagulan kullanıyor idi. Kronik oral antikoagulan kullanan hastaların ortalama operasyon süresi 212,4 dakika iken kullanmayan grupta 212,7 dakika olarak saptandı (p=0,86). Tahmini kan kaybı grup 1 için 205 ml, grup 2 için 223 ml idi (p=0,66). Dren çekilmesi sırasıyla grup 1 ve grup 2 için 2,6 gün ve 2,2 gündü (p=0,08). Hastanede kalış süresi grup 1 için 3,8 gün grup 2 için 3,2 gün olarak hesaplandı (p=0,09). Her iki grubun total komplikasyon oranları %16 olarak gerçekleşti. Bununla birlikte minör ve majör komplikasyon oranları arasında da istatistiksel fark izlenmedi.Sonuç: Robotik radikal prostatektomi kronik oral antikoagulan kullanan cerrahi açıdan riskli hastalarda güvenle uygulanabilir.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.